- Jehangir N Din (jehangirdin@hotmail.com), research fellow1,
- David E Newby, reader1,
- Andrew D Flapan, consultant cardiologist2
- 1Cardiovascular Research, University of Edinburgh, Edinburgh EH16 4SB
- 2Royal Infirmary of Edinburgh, Edinburgh EH16 4SA
- Correspondence to: J N Din
- Accepted 6 November 2003
Omega 3 fatty acids from fish and fish oils can protect against coronary heart disease. This article reviews the evidence regarding fish oils and coronary disease and outlines the mechanisms through which fish oils might confer cardiac benefits
Introduction
Omega 3 fatty acids from fish and fish oils can protect against coronary heart disease. Both health professionals and the public are increasingly interested in their role in the prevention and management of coronary heart disease. In this era of multiple pharmacological treatments for cardiovascular disease many believe that simple dietary interventions or nutritional supplements may be a more natural and acceptable method of providing benefits.
Several areas of uncertainty remain. The optimal intake of omega 3 fatty acids is not firmly established, nor is their mechanism of action fully understood. Some studies have produced conflicting results, and concerns have been increasing about environmental contamination of certain fish. This article reviews the current evidence regarding fish oils and cardiovascular disease, their possible mechanism of action, and potential future developments and research strategies.
Sources and selection criteria
We searched PubMed for relevant articles by using the key words “fish,” “fish oils,” “omega 3 fatty acids,” and “cardiovascular disease.” References identified in the search are on bmj.com
Summary points
Coronary heart disease is still the most common cause of death in the United Kingdom
Omega 3 fatty acids from fish and fish oils can protect against coronary heart disease
There is evidence to support the use of fish or fish oil supplements after myocardial infarction
The mechanisms by which fish oils confer their benefits are not fully understood
Unravelling these mechanisms may identify novel therapeutic targets and could help guide the development of future treatments for coronary heart disease
Future trials may identify other patients who could benefit, such as those with stable angina, risk factors for coronary heart disease, …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012